Characterisation of the vitreous proteome in proliferative diabetic retinopathy. - Wikidata - awgldk - TriplyDB

Characterisation of the vitreous proteome in proliferative diabetic retinopathy.

Characterisation of the vitreous proteome in proliferative diabetic retinopathy.

http://www.wikidata.org/entity/Q34184946

about

Pigment epithelium-derived factor: clinical significance in estrogen-dependent tissues and its potential in cancer therapy PEDF and its roles in physiological and pathological conditions: implication in diabetic and hypoxia-induced angiogenic diseases Proteomic interactions in the mouse vitreous-retina complex.Imbalance of the nerve growth factor and its precursor as a potential biomarker for diabetic retinopathy.Diabetes-related alterations in the enteric nervous system and its microenvironment.Development of Diagnostic Biomarkers for Detecting Diabetic Retinopathy at Early Stages Using Quantitative Proteomics Early urinary biomarkers of diabetic nephropathy in type 1 diabetes mellitus show involvement of kallikrein-kinin system.Functional and molecular characterization of ex vivo cultured epiretinal membrane cells from human proliferative diabetic retinopathy.Proteomic Analysis of Embryonic and Young Human Vitreous The Human Eye Proteome Project: perspectives on an emerging proteome.Proteome-base biomarkers in diabetes mellitus: progress on biofluids' protein profiling using mass spectrometry.Vitreous humor in the pathologic scope: insights from proteomic approaches.Effect of adiponectin on expression of vascular endothelial growth factor and pigment epithelium-derived factor: an in vitro study.A Review: Proteomics in Retinal Artery Occlusion, Retinal Vein Occlusion, Diabetic Retinopathy and Acquired Macular Disorders.Proteomic analyses of the vitreous humour.A Quantitative Proteomics Approach to Clinical Research with Non-Traditional Samples.Angiogenic Factors and Cytokines in Diabetic Retinopathy.The Human Eye Proteome Project: Updates on an Emerging Proteome.Change of ranibizumab-induced human vitreous protein profile in patients with proliferative diabetic retinopathy based on proteomics analysis.

P2860

Q26777495-CA4B9A48-EB8B-4129-83D0-FB98CE91DA23 Q27026916-3A2C1A3F-31E4-4958-B541-5F9FACAE80AF Q35060874-B983EC94-9FE6-4481-9655-752A6562E308 Q35234189-7156621B-C6A4-4FD9-B1F5-50F4760ADF6F Q35988135-0F53CA85-6D29-4FFE-9C49-1DE58F7D48A8 Q36311077-C6C14150-D750-412A-88F9-15F4C4D4DB53 Q36328641-55AFB0B6-9A62-40A4-97F4-822F494BDA94 Q37250409-C4754638-48A1-4D48-8354-3BDB2CFD0561 Q37415486-7337ED84-3E2B-4BB9-8B18-6D88D6A57D04 Q37689580-A514D067-DB5F-48E5-9055-2B20200EF771 Q38045278-A5F29ADF-276C-4C82-A2E4-B52A240577A8 Q38293676-3B1ADF2F-AA14-4FB9-A312-E99EA7DB810F Q38893364-A00793B0-637D-4560-9A5E-F97B8F6EFA1B Q39269575-DAB09E97-213F-4D5D-AEC9-F4FD6E9CC63A Q39553695-D031DB4B-5815-4A94-B235-6AD246862CCE Q41832554-80616620-4EE8-4337-A271-E75BBB77C3EB Q41883466-B4CC88FB-C4B6-45DB-9FE4-13817E067D45 Q51772900-75D6AD34-E243-47CD-9813-6E7BAFB742A9 Q54965847-94CE96AE-4AB2-4DF6-B8FE-EFE8FBF04DE1

P2860

Characterisation of the vitreous proteome in proliferative diabetic retinopathy.

http://www.wikidata.org/entity/Q34184946

description

2012 nî lūn-bûn

@nan

2012 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի մարտին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Characterisation of the vitreous proteome in proliferative diabetic retinopathy.

@ast

Characterisation of the vitreous proteome in proliferative diabetic retinopathy.

@en

Characterisation of the vitreous proteome in proliferative diabetic retinopathy.

@nl

type

label

Characterisation of the vitreous proteome in proliferative diabetic retinopathy.

@ast

Characterisation of the vitreous proteome in proliferative diabetic retinopathy.

@en

Characterisation of the vitreous proteome in proliferative diabetic retinopathy.

@nl

prefLabel

Characterisation of the vitreous proteome in proliferative diabetic retinopathy.

@ast

Characterisation of the vitreous proteome in proliferative diabetic retinopathy.

@en

Characterisation of the vitreous proteome in proliferative diabetic retinopathy.

@nl

P1433

Q34184946-29DB9A4B-8369-46A8-A18F-11210CD0FD82

P1476

Q34184946-921FFCB0-3BB2-4E04-8F00-6BBC6CC16F84

P2093

Q34184946-48E97E5F-F5E1-4410-9EB1-6AB9402AAF5F

Q34184946-813B9304-8337-45EF-A261-64D406BA04CB

Q34184946-D415B406-4930-481C-A2E0-6F19D71B69D3

Q34184946-D51D652B-646B-4A89-B30B-073F586D25C2

Q34184946-F7ABA126-35A7-4F76-9EED-782B9F27ECD9

P2860

Q34184946-08EBDE5F-672D-4BED-A4FE-986AEECDB52C

Q34184946-0DDB0EA3-5FD5-411C-A723-FCBA1EEC7A40

Q34184946-2643B1BF-BE5F-4C2B-8C11-3EF05C7F1605

Q34184946-2C78752F-3E9B-4AB1-8A78-652A11A67550

Q34184946-2CB2D1E6-A363-499D-B1A4-DAC5C4014A9A

Q34184946-304B497C-A517-48ED-B347-3D7FA6AF419D

Q34184946-3534B395-E8AF-4BF9-9993-639183EBE724

Q34184946-3D5E9FF5-B80F-4DDC-9D72-119D714F0F3C

Q34184946-409651FF-12D5-4439-BA60-E7D661F17DB6

Q34184946-49260259-FE88-4DE5-84C9-B1505A9955B0

P2888

Q34184946-CCB3CA89-152C-4E1C-95E9-B41925039D6E

P304

Q34184946-16E993AA-8EC3-46E1-816F-80D32FD4B28E

P31

Q34184946-E00DC802-0904-44AA-8DB5-F8654F42C14D

P356

Q34184946-EE08E3C8-3B48-43E0-9819-86A971EAF625

P433

Q34184946-EBCFF77B-CEC3-452C-B535-EE18FC90830E

P478

Q34184946-3982149C-E232-498F-A8C5-B62D82D9C9C0

P577

Q34184946-8BD50C16-9308-4159-A41E-32822E73DF91

P5875

Q34184946-5DFC9836-A0C0-4C2A-91A9-DA7FD7CCBB0E

P6179

Q34184946-3817FCD4-CBE5-4328-B194-CFD4ADD6D776

P698

Q34184946-532C481C-795E-4873-A25C-522DB6EC7434

P932

Q34184946-34E7CD23-E7A7-454B-B42A-A3D622E12310

P356

1477-5956-10-15

P1433

Proteome Science

P1476

Characterisation of the vitreous proteome in proliferative diabetic retinopathy.

@en

P2093

Chun Lei Xie

http://www.w3.org/2001/XMLSchema#string

Fang Wang

http://www.w3.org/2001/XMLSchema#string

Hao Wang

http://www.w3.org/2001/XMLSchema#string

Jian Wen Hu

http://www.w3.org/2001/XMLSchema#string

Le Feng

http://www.w3.org/2001/XMLSchema#string

P2860

Malate dehydrogenase: a model for structure, evolution, and catalysis

Structural insights into the hydrolysis of cellular nitric oxide synthase inhibitors by dimethylarginine dimethylaminohydrolase

Raf kinase as a target for anticancer therapeutics

Extracellular carbonic anhydrase mediates hemorrhagic retinal and cerebral vascular permeability through prekallikrein activation

Overexpression of dimethylarginine dimethylaminohydrolase protects against cerebral vascular effects of hyperhomocysteinemia.

Identification and localization of major soluble vitreous proteins in human ocular tissue.

Identification of an anti-aldolase autoantibody as a diagnostic marker for diabetic retinopathy by immunoproteomic analysis.

Profiling of vitreous proteomes from proliferative diabetic retinopathy and nondiabetic patients.

Identification of novel substrates for the serine protease HTRA1 in the human RPE secretome

P2888

1477-5956-10-15

P304

15

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1477-5956-10-15

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2012-03-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221888381

http://www.w3.org/2001/XMLSchema#string

P6179

1030956586

http://www.w3.org/2001/XMLSchema#string

P698

22390717

http://www.w3.org/2001/XMLSchema#string

P932

3310785

http://www.w3.org/2001/XMLSchema#string